MILLENNIUM MANAGEMENT LLC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 34 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q1 2018$1,845,000
+60.0%
105,101
+2.5%
0.00%0.0%
Q4 2017$1,153,000
-32.1%
102,516
-35.7%
0.00%
-33.3%
Q3 2017$1,698,000
+2.8%
159,436
-15.5%
0.00%0.0%
Q2 2017$1,652,000
+313.0%
188,777
+456.4%
0.00%
+200.0%
Q1 2017$400,000
-33.4%
33,928
-26.0%
0.00%0.0%
Q4 2016$601,000
+112.4%
45,858
+410.4%
0.00%0.0%
Q1 2015$283,0008,9840.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2018
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 69,100$1,220,0000.02%
MEEDER ASSET MANAGEMENT INC 3,446$61,0000.01%
METROPOLITAN LIFE INSURANCE CO/NY 4,573$80,7590.00%
Ameritas Investment Partners, Inc. 958$17,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,173$321,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 7,639$135,0000.00%
NORTHERN TRUST CORP 162,102$2,863,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 12,100$207,0000.00%
RHUMBLINE ADVISERS 15,377$272,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 252,134$4,452,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders